Clin2
NCT06542887Possibly a fitNot yet recruiting

Black seed oil for children with ADHD

ADHD

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This trial tests whether adding black seed oil to a stable dose of atomoxetine can help children with ADHD. It is a simple supplement study that looks for improvement in ADHD symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
60 people
Ages
6 years to 12 years
Study type
Interventional

Who can take part

  • You must be between 6 and 12 years old.
  • You must be able to swallow capsules.
  • You must have an official ADHD diagnosis (based on DSM-5 criteria).
  • You must have been taking a steady dose of atomoxetine for at least 12 weeks.
  • You cannot have other major conditions like autism, anxiety, OCD, or a bleeding disorder.
  • You cannot have diabetes, liver or kidney problems, or take blood thinners.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07364331Recruiting
Omega-3 supplements for ADHD symptoms

This trial tests whether omega-3 fatty acids can improve attention and hyperactivity in people with ADHD. It compares omega-3 treatment against a placebo to see if it helps reduce symptoms.

Taichung
NCT04216186Recruiting· Phase 3
Coenzyme Q for children with ADHD

This trial tests whether taking coenzyme Q can improve symptoms of attention-deficit/hyperactivity disorder (ADHD) in children. It may help if your child has ADHD, but it excludes certain other conditions.

Tanta
NCT03781765Recruiting· Phase 4
Testing stimulant vs non-stimulant ADHD treatments in young kids

This study compares stimulant and non-stimulant ADHD medicines in kids who have not taken ADHD medication before. It also studies how these treatments affect brain “reward” processes, which may be linked to substance-use risk.

New York, New York
NCT06841666Not yet recruiting· Early Phase 1
Atomoxetine for bedwetting in children with ADHD

This study tests whether a medication called atomoxetine (Strattera) can help reduce nighttime bedwetting in children with ADHD. If your child has both ADHD and primary nocturnal enuresis (bedwetting that has never stopped for 6 months), this trial may offer a new treatment option.

NCT05916339Recruiting· Phase 4
Managing ADHD symptoms in autistic children with a study plan

This Phase 4 study looks at how to manage ADHD symptoms in children and teens who also have autism. It may help your child’s care team learn what treatment routines work best in real life settings.

Irvine, California
NCT07650643Not yet recruiting· Phase 4
Brain wave patterns to predict ADHD medication response

This study uses brain scans (EEG) to understand which children with ADHD will respond well to stimulant medications. The goal is to help doctors choose the right treatment faster by looking at brain activity patterns before starting medication.

Brookline, Massachusetts

Hear when a new ADHD trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.